A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE

Graduate Medical Education (GME)

Graduate Medical Education (GME)
Welcome to the City of Hope Office of Graduate Medical Education (GME).  GME is an essential and integral part of the academic atmosphere and clinical environment necessary to accomplish the mission of City of Hope. All residency and clinical fellowship programs at City of Hope are overseen by the Designated Institutional Official, the Director of Graduate Medical Education & Clinical Training and by the Graduate Medical Education Committee (GMEC).  The office of GME offers a variety of resources to assist residents, fellows, faculty and staff in meeting their clinical training goals and objectives.  The office of GME is available to assist you, and we encourage you to contact us with any questions or concerns.
 
Clinical Residency and Fellowship Programs
 
City of Hope's Clinical Training Programs offer excellent opportunities for physicians interested in expanding their knowledge base and clinical expertise in specialty and subspecialty areas. Our clinical training programs offer intensive didactic as well as hands-on training by instructors who have made significant contributions to cancer research and clinical practice.
 
Graduate Medical Education Committee (GMEC)
 
Our Graduate Medical Education Committee provides oversight, guidance, and support to ensure the quality of education and work environment for all our trainees. Responsibilities of the GMEC include the following:

  • Develop and review policies and procedures that affect both ACGME-accredited and non-accredited clinical training programs and their trainees
     
  • Maintain oversight of and liaison with clinical program directors
     
  • Conduct regular reviews of ACGME-accredited clinical training programs in accordance with the Common Program Requirements and the RRC Program Requirements
     
  • Review and approve non-ACGME accredited clinical training programs to ensure that they meet equivalent standards to those required for the accredited programs
     
  • Review and approve changes to training programs which could affect educational quality or require ACGME approval
     
  • Provide a forum for exchange of information among all parties involved in graduate medical education
     
  • Review Letters of Report concerning all ACGME-accredited clinical training programs and monitor action plans for correction in areas of non-compliance
     
 

House Staff Application

Please contact Graduate Medical Education for a Clinical Residency or Fellowship application.
 
Graduate Medical Education
1500 E. Duarte Road
Duarte, CA 91010
(626) 256-4673, ext. 63889

Agreement Checklist
 

Resident and Fellows Forum

The City of Hope Department of GME & Clinical Training sponsors a Resident and Fellow Forum. This forum provides a formal platform for our trainees to communicate with each other in a comfortable and collegial environment. The forum occurs at least once a quarter, and is attended by the Director of GME for the first portion, allowing exchange of information, as required or requested. Thereafter, the Director of GME leaves, and the trainees are free to discuss whatever aspect of their programs (or lives) they wish.
 
All GME trainees at City of Hope are automatically members of this forum and are  welcomed and encouraged to attend. The forum provides an open, group discussion that allows residents and fellows to communicate and exchange information on their educational and work environments, their programs, and other relevant issues they may face during training, as well as promote the well-being, interests and education of GME trainees. The forum strives to keep all residents and fellows informed about important issues that impact their professional lives as well as provide an organized voice to raise and resolve concerns for City of Hope trainees.
 
The forum is co-chaired by two active trainee members of the GMEC, nominated and elected by their peers. Any issues or topics discussed during the forum can warrant further discussion or presentation to the GMEC if decided by the forum. The forum co-chairs/GMEC representatives can also present any issues to the committee during the GMEC meetings.

Salaries and Financial Information

 

COH PGY Salary Scale 2011-2014
 

PGY

Salary

Monthly

Annual

1

$ 3,663.05

$ 43,956

2

$ 4,098.08

$ 49,176

3 $ 4,440.34 $ 53,284
4 $ 4,784.95 $ 57,419

5

$ 5,120.29

$ 61,443

6

$ 5,467.21

$ 65,606

7

$ 5,793.30

$ 69,519
 

Trainee Benefits/Agreement

Physician-in-Training Agreements
 
 
City of Hope Trainee Current Benefits
 
Medical Benefits
Aetna PPO or HMO Plan or Kaiser HMO options; Prescription drug program; Option for dependent care coverage (shared by Trainee).
 
Dental Benefits
Choice of Aetna Dental PPO, Aetna DMO; Preventive, basic, and major dental service levels.
 
Vision Benefits
Optional vision plan is available if Trainee elects this coverage (this benefit is voluntary).
 
Disability Insurance
Short Term Provides 60% of salary for illness up to 90 days of absence starting on the 8th day of illness. Long Term is available and provides 60% of salary for illness after 90 days of absence if Trainee elects this coverage (this benefit is voluntary).
 
Basic Life and Accidental Death and Dismemberment Insurance
$50,000 of group term life insurance provided by the COHMG is provided. There is a cost of coverage in excess of $50,000 if Trainee elects to increase this coverage.
 
Retirement Plan
Optional 403(b) retirement plan is available if Trainee elects to contribute (this benefit is voluntary).  The 403(b) Tax Deferred Annuity Plan allows you to set aside money from your pay to save for retirement.  Your deferrals are taken on a pre-tax basis, so you do not pay taxes on the money or any earnings until you take a distribution from the plan.  This lowers your current taxes.
 
The Plan is administered by TIAA-CREF.  There are a variety of investment options from which to choose to build your own portfolio, or you can decide to invest in a Lifecycle Fund appropriate for your expected retirement year.  You have online access to your account 24/7 through the TIAA-CREF/City of Hope website (www.tiaa-cref.org/coh) or you can speak with a representative during business hours (800-842-2252).  You may also arrange to meet with a TIAA-CREF counselor in person at no cost to you to discuss your retirement needs.
 
You may defer up to the government limits each year (for 2013 $17,500 under age 50 and $23,000 age 50 and over).  You can start, stop or change your contribution amounts at any pay period by submitting a new Salary Reduction form.  Loans and hardship withdrawals are available in this plan. To enroll, first go to the TIAA-CREF/COH website and open an account.  Then print off a Salary Reduction form, sign it, and return it to Benefits and Employee Services.
 
Supplemental Term Life Insurance
Additional term life insurance may be purchased by Trainee and dependents (this benefit is voluntary).
 
Employee Assistance Program
Five (5) covered visits per year.
 
 

GME Policies and Procedures

GME Helpful Links and Resources

Current Residents and Fellows

________________________________________________________________________________________________________________
Breast Surgical Oncology Fellowship
 
 
 

Allison DiPasquale, M.D.
Breast Surgical Oncology
Year 1
 
_________________________________________________________________________________________________________________________________
Diabetes Endocrinology and Metabolism Fellowship
 
Vishwanath Pattan, M.D.
Diabetes Endocrinology and Metabolism
Year 1
Tatiana Sams, M.D.
Diabetes Endocrinology
and Metabolism
Year 1
Jean Huang, M.D.
Diabetes Endocrinology
and Metabolism
Year 2
 
 
_________________________________________________________________________________________________________________________
Hematology/Bone Marrow Transplantation-HCT Fellowship
 
Alex Herrera, M.D.
Hematology/Bone Marrow Transplantation-HCT
Year 1                                                                                       
Monzr Al Malki, M.D.                                                 
Hematology/Bone Marrow Transplantation-HCT                                                                   
Year 1          
                                                                     
 
__________________________________________________________________________________________________________________________
Hematology Oncology Fellowship
 
May Cho, M.D.
Hematology Oncology Fellowship
Year 1
Anh Pham, M.D.
Hematology Oncology Fellowship
Year 1

Dai Chu Nguyen Luu, M.D.
Hematology Oncology Fellowship
Year 2                                                           

Niki Tank, M.D.                        
Hematology Oncology Fellowship
Year 2
                                                                                                                           

Zeynep Eroglu, M.D.
Hematology Oncology Fellowship
Year 3

Odicie Fielder-Kimbrough, M.D.
Hematology Oncology Fellowship
Year 3
                                              
 
_____________________________________________________________________________________________________________
Hematopathology Fellowship
 
 
Lawrence Low, M.D., Ph.D.
Hematopathology Fellowship
Year 1
 
                                                                                                                                                          
Liping Song, M.D., Ph.D.
Hematopathology Fellowship
Year 1
                                                                        
 
_________________________________________________________________________________________________________________________________
Radiation Oncology Residency
 
 
Wei-Hsien Hou, M.D., Ph.D.
Radiation Oncology Residency
Year 1                                                                             
 
 
 
 
Lindsay Jensen, M.D.        
Radiation Oncology Residency
Year 2                                                                                                                                                                                                                                                                     
 
 
Benjamin Cahan, M.D.        
Radiation Oncology Residency
Year 3
 
Mathew Hall, M.D.
Radiation Oncology Residency
Year 4
 
________________________________________________________________________________________________________________________________
Surgical Oncology Fellowship
 
Anne Falor, M.D.
Surgical Oncology Fellowship
Year 1
                                                            
Emily Fontenot Marcinkowski, M.D.
Surgical Oncology Fellowship
Year 1                                    
Michael White, M.D.
Surgical Oncology Fellowship
Year 1
John Hamner, M.D.
Surgical Oncology Fellowship
Year 2

 
Rondi Kaufmann, M.D.
Surgical Oncology Fellowship
Year 2
Shaila Merchant, M.D.
Surgical Oncology Fellowship
Year 2
Audrey Choi, M.D.
Surgical Oncology Fellowship
Research Resident
Aaron Lewis, M.D.
Surgical Oncology Fellowship
Geena Wu, M.D.
Surgical Oncology Fellowship
Research Resident
   
 
________________________________________________________________________________________________________________________________
Urology and Urologic Oncology Fellowship
 
 
 
 
 
 
Jason Bourque, M.D.
Urology and Urologic Oncology Fellowship                                                  
Year 1
                                                                                                                                                                           
 
 
Dennis Lee, M.D.                              
Urology and Urologic Oncology
Fellowship
Year 1                                                                                              
Derek Prabharasuth, M.D.
Urology and Urologic Oncology
Fellowship
Year 1                                                     
Kristina Wittig, M.D.
Urology and Urologic Oncology
Fellowship
Year 2
Ali Zhumkhawala, M.D.
Urology and Urologic Oncology
Fellowship
Year 2
   
 
Residents and Fellows
New Innovations
City of Hope uses New Innovations for  management of our clinical trainees.
 
 
GME Resources
Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
NEWS & UPDATES
  • Donating blood and platelets saves lives. We all know this. Yet every summer, potential blood donors become distracted by vacations and schedule changes. As a result, blood donations fall dramatically across the nation, leaving hospitals frantically trying to bring in much-needed blood for their patients. Earli...
  • To be a great cancer hospital, you need a great oncology program. Just ask City of Hope – and Becker’s Hospital Review. The health care publishing industry stalwart, described as the “leading hospital magazine for hospital business news and analysis for hospital and health system executives,” recently selected ...
  • Diagnostic errors are far from uncommon. In fact, a recent study found that they affect about 12 million people, or 1 in 20 patients,  in the U.S. each year. With cancer, those errors in diagnosis can have a profound impact. A missed or delayed diagnosis can make the disease that much harder to treat, as the Ag...
  • Eleven years ago, lymphoma patient Christine Pechera began the long road toward a cancer-free life. She had been diagnosed with non-Hodgkin lymphoma and told by doctors elsewhere that her lifespan likely would be measured in months, not years. Refusing to give up, she came to City of Hope for a second opinion. ...
  • Brain surgery is not for the faint of heart. It takes courage, as well as curiosity and compassion. The truly great surgeons also have a desire to find new, and better ways, of healing the brain. Enter Behnam Badie, M.D., chief of neurosurgery at City of Hope. Now a pioneer in brain tumor treatment, Badie enter...
  • Elizabeth Budde, M.D., Ph.D., wants to encourage infighting. She aims to turn the immune system on itself — to the benefit of patients with acute myeloid leukemia, or AML. AML arises when abnormal white blood cells grow out of control, amassing in the bone marrow and interfering with normal blood cell developme...
  • Six, to date; more soon. Outpatient bone marrow transplants, that is. Finding new ways to deliver quality care with the greatest benefit is a priority for a patient-centered institution like City of Hope. For example, not every bone marrow transplant patient needs to check into the hospital for treatment. In fa...
  • The best measure of success in the fight against cancer is in lives saved and families intact, in extra days made special simply because they exist. Yuman Fong, M.D., chair of the Department of Surgery at City of Hope, understands what precedes that special awareness. When cancer strikes, one minute a person ma...
  • In cancer, expertise matters. So do survival rates, patient safety, patient services and many other factors. City of Hope understands this, as does U.S.News & World Report. The magazine’s 2014-2015 list of best hospitals for cancer once again includes City of Hope, ranking the institution 12 out of 900 elig...
  • At 29, Kommah McDowell was a successful young professional engaged to be married to her best friend. She worked in the financial services sector and kick-boxed to keep in shape and to relax. Then came the diagnosis of triple-negative inflammatory breast cancer, a rare and very aggressive form of breast cancer. ...
  • The well-known drug tamoxifen might not always be the best choice for premenopausal women who have undergone treatment for breast cancer and face a heightened risk of recurrence. A new study suggests that the aromatase inhibitor exemestane, or Aromasin, works slightly better than tamoxifen in preventing cancer ...
  • At age 44, Bridget Hanchette, a mother of three from La Crosse, Wisconsin, was diagnosed with grade IV glioblastoma, the most aggressive type of malignant brain tumor. The cancer grows and spreads quickly, making it difficult to treat. Most patients with this diagnosis are not given much hope, but Hanchette’s i...
  • Survival rates for childhood cancer have improved tremendously over the past few decades, but postcancer care hasn’t always kept up. More children than ever are now coping with long-term complications and side effects caused by their disease and treatment — one of those being learning difficulties. A new ...
  • When Sheldon Querido, a retired manufacturer’s representative, was diagnosed with bladder cancer, his doctor told him that he’d need to have his bladder removed – and that he’d have to wear an external urine-collection bag for the rest of his life. “My first response was ‘I donR...
  • To stop smoking, two approaches might be better than one. A new study has found that using the medication varenicline, or Chantix – along with nicotine patches – was more effective than the medicine alone in helping people quit. The study, conducted by Stellanbosch University in Cape Town, South Africa, and pub...